How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Animal Health Dosing Syringe Market
- By Product Type: Disposable Dosing Syringes, Reusable Dosing Syringes, Automatic Dosing Syringes, Pre-filled Dosing Syringes, Oral Dosing Syringes
- By Animal Type: Companion Animals, Livestock, Poultry, Aquatic Animals, Equine
- By Application: Oral Medication Delivery, Injectable Medication Delivery, Vaccination, Nutritional Supplement Administration, Hormonal Treatment
- By End User: Veterinary Clinics, Animal Farms, Pet Owners, Animal Hospitals, Research Laboratories
- By Material: Plastic Syringes, Glass Syringes, Silicone-coated Syringes, Stainless Steel Syringes
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Disposable Dosing Syringes leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 303 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the Animal Health Dosing Syringe Market report
A complete, evidence-based study - 12 chapters and 127 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Animal Type 5
Application 5
End User 5
Material 4
Companies profiled
Becton Dickinson and Company (BD)
Zoetis Inc.
Merial (a Boehringer Ingelheim company)
Elanco Animal Health
Vetoquinol SA
Dechra Pharmaceuticals PLC
Ceva Santé Animale
Henry Schein Animal Health
Bimeda Inc.
Patterson Companies Inc.
Merial Ltd.
Jorgensen Laboratories Inc.
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Becton Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Zoetis Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Merial (a Boehringer Ingelheim company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Elanco Animal Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Vetoquinol SA
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Dechra Pharmaceuticals PLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Ceva Santé Animale
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Henry Schein Animal Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Bimeda Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Patterson Companies Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Merial Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Jorgensen Laboratories Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Kent Scientific Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Animalcare Group plc
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Norbrook Laboratories Limited
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,015M by 2033 · 5.2% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Disposable Dosing Syringes37.8
- Reusable Dosing Syringes12.7
- Automatic Dosing Syringes18.3
- Pre-filled Dosing Syringes19.9
- Oral Dosing Syringes11.3
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,538M → $2,192M · 4.5%
Europe$1,072M → $1,464M · 4.0%
Asia Pacific$978.8M → $1,642M · 6.7%
Latin America$605.9M → $993.1M · 6.4%
Middle East and Africa$466.1M → $669.3M · 4.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →5.202026
5.212027
5.222028
5.242029
5.242030
5.252031
5.282032
5.272033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Becton Dickinson and Company (BD)24.6
- Zoetis Inc.10.4
- Merial (a Boehringer Ingelheim company)11.8
- Elanco Animal Health6.7
- Vetoquinol SA11.4
- Dechra Pharmaceuticals PLC7.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type34.0%
Animal Type11.5%
Application21.6%
End User20.3%
Material12.7%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.5
- Europe21.0
- Asia Pacific23.6
- Latin America14.3
- Middle East and Africa9.6
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | 77 | 94 | 87 | 94 | 87 | 73 | 85 |
| Zoetis Inc. | 89 | 79 | 90 | 91 | 76 | 84 | 85 |
| Merial (a Boehringer Ingelheim company) | 76 | 85 | 75 | 71 | 70 | 66 | 74 |
| Elanco Animal Health | 82 | 65 | 66 | 81 | 78 | 74 | 74 |
| Vetoquinol SA | 61 | 68 | 59 | 67 | 52 | 65 | 62 |
| Dechra Pharmaceuticals PLC | 67 | 63 | 63 | 70 | 50 | 66 | 63 |
| Ceva Santé Animale | 54 | 45 | 66 | 44 | 56 | 55 | 53 |
| Henry Schein Animal Health | 50 | 58 | 54 | 54 | 35 | 37 | 48 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Becton Dickinson and Company (BD)
- Zoetis Inc.
- Merial (a Boehringer Ingelheim company)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Becton Dickinson and Company (BD) | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Zoetis Inc. | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Merial (a Boehringer Ingelheim company) | ◐ | ✓ | ✓ | ◐ | ✓ | − |
| Elanco Animal Health | ◐ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Vetoquinol SA | ◐ | ✓ | − | ◐ | − | − |
| Dechra Pharmaceuticals PLC | ◐ | ◐ | ◐ | ✓ | − | − |
| Ceva Santé Animale | ◐ | ◐ | − | − | − | ◐ |
| Henry Schein Animal Health | − | ◐ | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Becton Dickinson and Company (BD)85
2Zoetis Inc.85
3Merial (a Boehringer Ingelheim company)74
4Elanco Animal Health74
5Dechra Pharmaceuticals PLC63
6Vetoquinol SA62
7Ceva Santé Animale53
8Henry Schein Animal Health48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Becton Dickinson and Company (BD)Zoetis Inc.
Challenger2
Strong scale, closing on the leaders.
Merial (a Boehringer Ingelheim company)Elanco Animal Health
Contender2
Focused players with pockets of strength.
Vetoquinol SADechra Pharmaceuticals PLC
Niche2
Specialists in a single segment or region.
Ceva Santé AnimaleHenry Schein Animal Health
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Animal Health Dosing Syringe Market — a $398M beachhead inside a $6.42B market.
Beachhead (SOM)$398Mobtainable near-term
Serviceable (SAM)$2.26Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Disposable Dosing Syringes
Best fit — highest urgency & budget in Product Type.
Economic buyer81 fit
Reusable Dosing Syringes
Strong fit — clear ROI and a fast path to value.
End user67 fit
Automatic Dosing Syringes
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Animal Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales43%
Partner / channel26%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Animal Health Dosing Syringe Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified23%
Evaluation11%
Closed-won8%
$12.5KCAC
$49KLTV
3.9:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Animal Health Dosing Syringe Market is a resilient opportunity — $1.57B by 2033, compounding at 4.9%.
TAM · 2025$1.07Btoday
TAM · 2033$1.57Bforecast
CAGR4.9%2027–2033
Cumulative$11.7Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$1.57BTotal addressable market
SAM$596MServiceable available market
SOM$101MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.9% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$1.57BLarge & growingTAM by 2033 at 4.9% CAGR
$596MServiceable nowreachable with today’s model
$101MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$1.22BBear3.2% CAGR
$1.57BBase4.9% CAGR
$2.00BBull6.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Animal Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Animal Health Dosing Syringe Market — a $2.42B market by 2033. Plan: grow share from 11.2% to 18.8%.
Market size · 2033$2.42Btotal addressable
Market CAGR4.1%2027–2033
Target share18.8%from 11.2% today
Revenue ambition$455Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 11.2% | 18.8% | Ahead |
| Revenue | $279M | $455M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 31.8% | 42.2% | Ahead |
| Customer retention | 88.8% | 94.7% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Animal Type capability
A defensible second engine — invest in Animal Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Animal Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $58M capacity & capability investment
- Greenlight bolt-on M&A in Animal Type
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossAt risk
- Input-cost & supply riskAt risk
- Regulatory / policy changeAt risk
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Animal Health Dosing Syringe Market conversation — a $9.80B market you can size, segment and defend in minutes.
Market size · 2033$9.80Btotal opportunity
Growth10.2%CAGR to 2033
Addressable buyers1,347+accounts in scope
Typical ROI5.7×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.7×return on cost, year one
< 3 mopayback period
$63K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Becton Dickinson and Company (BD)Zoetis Inc.Merial (a Boehringer Ingelheim company)Elanco Animal HealthVetoquinol SADechra Pharmaceuticals PLCCeva Santé AnimaleHenry Schein Animal Health+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Animal Health Dosing Syringe Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Animal Health Dosing Syringe Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Humidification Chamber Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportAnimal Health Diagnostics and Therapeutics Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportInfant Resuscitation Masks Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportAnimal Health Diagnosis Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportHeated Humidifier Devices Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportAnimal Health Consulting Service Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportMedical Walkers Market
Market size, share, segmentation and regional forecast.
$448M market · 2025 base year
View reportAnimal Healthcare Disinfectant Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportPOC Cardiovascular Diagnostic Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportLaparotomy Sponges Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportElectrocardiograph (ECG) Market
Market size, share, segmentation and regional forecast.
$327M market · 2025 base year
View reportAnimal Hair Allergy Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.